spite the fact that it exhibits potent effects not too dissimilar from those evoked by aspirin (4) . Furthermore, aspirin is rapidly (i.e., within minutes) hydrolyzed to salicylic acid in the body (5) , and it is difficult to detect inhibition of prostaglandin synthetase in other tissues with doses sufficient to inactivate platelet cyclo-oxygenase (6) (7) (8) . It has been shown that the prostaglandin synthetase of intact tissues, other than platelets, is relatively refractory to aspirin and inhibition requires very much higher concentrations over protracted time periods (7) (8) (9) . It therefore seems probable that, in addition to inhibition of cyclo-oxygenase activity, aspirin and indomethacin may have in common some other biochemical effect that is also shared by sodium salicylate.
Hamberg and Samuelsson originally demonstrated (10) that human platelets can convert exogenously added arachidonate into 12L-hydroxy-5,8,10,14-eicosatetraenoic acid (HETE) as well as to fatty acid cyclo-oxygenase products. The existence of a lipoxygenase pathway distinct from cyclo.oxygenase activity was supported by the fact that platelet suspensions produced 3 times more HETE from arachidonate in the presence of aspirin or indomethacin despite the virtually total inhibition of cyclo-oxygenase activity by these substances (11) . In fact, when horse platelets are stimulated by aggregating agents, approximately 75% of the arachidonate released from endogenous phospholipids by the action of phospholipases is metabolized via lipoxygenase (12, 13) .
Although the possible biological activities of the products of the metabolism of arachidonate via lipoxygenase have not been elucidated, HETE, the end product of this metabolic route in human platelets (10, 14) , appears to be chemotactic for human polymorphonuclear leukocytes (15, 16) . In addition, a lipid fraction from Escherichia coli having chemical and chromatographic properties similar to HETE has chemotactic activity with human polymorphs and rabbit alveolar macrophages (17) . The unstable lipoxygenase -product (14), 12L-hydroperoxy-5,8,10,14-eicosatetraenoic acid (HPETE), may also play as yet unrecognized, important biological functions. For example, various fatty acid hydroperoxides that are analogs of HPETE have been shown to inhibit the formation of prostacyclin via prostacyclin synthetase in porcine aorta (18) and other tissues (19) . In addition, the release of anaphylactic mediators from perfused guinea pig lung is enhanced by hydroperoxy-fatty acids (20, 21) .
Because of the possible physiological and pathological importance of HPETE (10, 14) . The second, eluting at 28 min, cochromatographed on thin-layer chromatography with the putative HPETE identified above. After reduction with borohydride, this compound cochromatographed with HETE on thin-layer and high-pressure chromatography systems and yielded the same gas chromatograph/mass spectrum described above. Finally, addition of the putative HPETE to reaction mixtures containing lipoxygenase and peroxidase activities gave rise to a product cochromatographing with HETE. Therefore, these data are consistent with this reducible compound being HPETE.
RESULTS AND DISCUSSION
When platelets, prepared by differential centrifugation from freshly drawn human blood (12) , were lysed in hypotonic medium by repetitive freeze-thawing, greater than 60% of the lipoxygenase activity appeared in the 100,000 X g supernatant (unpublished observation). The ability of this lipoxygenase preparation to metabolize arachidonate was markedly influenced by the presence of aspirin or indomethacin. As illustrated in Fig. 1 Further evidence for the significance of this metabolic effect was derived from experiments in which platelets labeled with [1-14C]arachidonate in their phospholipids were challenged with the aggregating agent, thrombin, which released the labeled, endogenous arachidonate (12, 13) (Fig. 3) . Indomethacin affected the metabolism of this released arachidonate by initially diverting substrate from cyclo-oxygenase to the lipoxygenase, as reflected by higher HETE production. However, it was also apparent that indomethacin inhibited the conversion of HPETE to HETE. As observed with lysed human platelet supernatants ( Fig. 1 ) and intact cells using exogenously added arachidonate (Fig. 2) , in the presence of indomethacin there was an increase in HPETE and relatively less HETE production.
The effects of aspirin and indomethacin were not limited to human platelets, but were also observed in other species and tissues, such as 3T3 fibroblasts, rat neutrophils, and rat macrophage homogenates (not shown). For 10 ,uM indomethacin, and 0.97 at 400,uM indomethacin.
One of the major dilemmas in the rationalization of the mechanism of action of anti-inflammatory, analgesic, and antipyretic drugs according to the prostaglandin synthetase hypothesis has been the explanation of the mode of action of sodium salicylate. Whereas aspirin and indomethacin inhibit cyclo-oxygenase activity, salicylate does not appear to have this effect in vitro (1, 3, 4, 23) . However, as illustrated in Fig. 4 , sodium salicylate shares with indomethacin and aspirin the pronounced effect on the metabolism of arachidonate via the lipoxygenase pathway. The half-maximal inhibition of HETE production and the concomitant rise in the amount of HPETE produced occurred at approximately 100 ,AM sodium salicylate.
Because aspirin, when taken orally, irreversibly inhibits human platelet cyclo-oxygenase activity (3), it was of interest to determine whether aspirin would irreversibly inhibit HPETE peroxidase activity. As shown in Table 1 Blood was drawn from a healthy human volunteer before and 2 hr after a 975-mg oral dose of aspirin, and platelets were prepared by differential centrifugation. Assays were conducted with intact platelets in 50 mM Tris-HCl (pH 7.4) containing 100 mM NaCl with exogenously added 80 ,uM [1-14C] also demonstrated by direct experiments (Table 2 ). When human platelets were preincubated, lysed, and subjected to gel filtration to remove free drug, the reversibility of aspirin, indomethacin, and salicylate inhibition became apparent. The results also show that after these treatments addition of fresh drug was still effective in the platelet preparations. Therefore, although indomethacin and aspirin, but not salicylate, are irreversible inhibitors of cyclo-oxygenase, all of these drugs share the common property of reversible inhibition of HPETE peroxidase activity. In the presence of these inhibitors, the rate of conversion of HPETE to HETE decreases to a rate that is equivalent to that of the nonenzymatic decomposition of the hydroperoxy-fatty acid. It is conceivable, therefore, that with these drugs the increase in HPETE, or an as yet unknown, biologically active metabolite of the hydroperoxy-fatty acid, may be of greater clinical importance than the inhibition of HETE formation.
Because of the similarity of the effects of indomethacin, aspirin, and sodium salicylate on HPETE peroxidase activity, it is tempting to speculate that at least some of the pharmacological actions that these drugs have in common may be related to their ability to influence arachidonate metabolism via the lipoxygenase pathway. For example, because prostacyclin is hyperalgesic (24, 25) and HPETE analogs inhibit prostacyclin synthetase (18, 19) , part of the analgesic activity of these drugs may be explained by their common ability to elevate HPETE at the expense of HETE, thereby aiding in the inhibition of prostacyclin production. In addition, because HETE appears Human platelets obtained by centrifugation were preincubated for 1 hr at room temperature in 50 mM Tris-HCl, pH 7.4/0.1 M NaCl/1 mM EDTA/1 mg of glucose per ml in the absence or presence of indomethacin, aspirin, or sodium salicylate. Platelets were pelleted by centrifugation and frozen-thawed three times in 50 mM Tris-HCl (pH 7.4). Aliquots (0.5-ml) were applied to 0.7 X 20 cm Sephadex G-25 (medium) columns that had been equilibrated with 50 mM Tris-HCl (pH 7.4) and were eluted with the same buffer. The protein eluting in the breakthrough fractions was assayed in 50 mM Tris-HCl (pH 7.4) in the presence or absence of the various drugs. Values are HPETE/(HPETE + HETE). All ratios are +0.05.
to be chemotactic (15, 17) , inhibition of its production may be in part related to the drugs' anti-inflammatory activity [i.e., blocking the recruitment of phagocytic cells (26, 27) 
